News
XTNT
0.6160
+0.93%
0.0057
Weekly Report: what happened at XTNT last week (1201-1205)?
Weekly Report · 12h ago
Xtant Medical Sells Assets to Companion Spine
TipRanks · 5d ago
Press Release: Xtant Medical Completes Sale of its Coflex(R) Assets and Paradigm OUS Businesses to Companion Spine
Dow Jones · 12/01 21:05
Xtant Medical Completes Sale of its Coflex® Assets and Paradigm OUS Businesses to Companion Spine
PR Newswire · 12/01 21:05
Weekly Report: what happened at XTNT last week (1124-1128)?
Weekly Report · 12/01 09:52
Weekly Report: what happened at XTNT last week (1117-1121)?
Weekly Report · 11/24 09:55
Weekly Report: what happened at XTNT last week (1110-1114)?
Weekly Report · 11/17 09:55
Xtant Medical Reports Strong Q3 2025 Results
TipRanks · 11/12 03:59
Xtant Medical Holdings’ Earnings Call: Positive Growth Amid Challenges
TipRanks · 11/12 00:13
Xtant Medical Holdings Price Target Cut to $1.50/Share From $2.00 by BTIG
Dow Jones · 11/11 16:41
Xtant Medical Holdings Is Maintained at Buy by BTIG
Dow Jones · 11/11 16:41
BTIG Maintains Buy on Xtant Medical Hldgs, Lowers Price Target to $1.5
Benzinga · 11/11 16:32
Xtant Medical reiterates $131M–$135M 2025 revenue guidance as company pursues strategic asset sale and ramps orthobiologics innovation
Seeking Alpha · 11/11 15:52
Xtant Medical Holdings: Buy Rating Affirmed on Strong Financial Performance and Strategic Growth Potential
TipRanks · 11/11 15:15
Xtant Medical Hldgs Affirms FY2025 Sales Guidance of $131.000M-$135.000M vs $129.950M Est
Benzinga · 11/10 22:58
Xtant Medical GAAP EPS of $0.01 beats by $0.02, revenue of $33.26M beats by $0.56M
Seeking Alpha · 11/10 22:15
Xtant Medical Hldgs Q3 EPS $0.01 Beats $(0.01) Estimate, Sales $33.300M Beat $32.700M Estimate
Benzinga · 11/10 21:39
Xtant Medical reports Q3 EPS 1c vs. (4c) last year
TipRanks · 11/10 21:37
Xtant Medical still sees 2025 revenue $131M-$135M vs. $117.27M in 2024
TipRanks · 11/10 21:36
*Xtant Medical Holdings Backs FY25 Rev $131M-$135M >XTNT
Dow Jones · 11/10 21:32
More
Webull provides a variety of real-time XTNT stock news. You can receive the latest news about Xtant Medical through multiple platforms. This information may help you make smarter investment decisions.
About XTNT
Xtant Medical Holdings, Inc. is a global medical technology company. The Company is focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. Its biomaterial products include OsteoSponge, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, OsteoVive, OsteoFactor, line of 3Demin products, as well as other allografts. It offers a comprehensive line of products that are used to treat a variety of spinal and sacroiliac conditions, including trauma, degeneration, deformity and tumor. Its key spinal implant product lines include Cervical products, Thoracolumbar products, Sacroiliac Joint products, and Interbody products.